Technologies for deriving primary tumor cells for use in personalized cancer therapy
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
For decades, immortal cancer cell lines have constituted an accessible, easily usable set of biological models to investigate cancer biology and explore the potential efficacy of anticancer drugs. However, numerous studies suggest that these cell lines poorly represent the diversity, heterogeneity and drug-resistant tumors occurring in patients. The derivation and short -term culture of primary cells from solid tumors have thus gained significant importance in personalized cancer therapy. This review focuses our current understanding and the pros and cons of different methods for primary tumor cell culture. Furthermore, various culture matrices like biomimetic scaffolds, chemically defined media supplemented with essential nutrients have been prepared for different tissues. These well characterized primary tumor cells redefine cancer therapies with high translational relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Marker-independent identification of glioma-initiating cells
Clément, V., Marino, D., Cudalbu, C., Hamou, M., Mlynárik, V., de Tribolet, N., Dietrich, P., Rolf Gruetter, A., Hegi, M. E., & Radovanovic, I. (2010) · Nature Methods · doi:10.1038/nmeth.1430 · Cited by 81
RetractedIdentification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598 · cited 1×
“In vitro, tumor cells can proliferate indefinitely by clonal expansion and serial passaging and the malignancy of these cells can be determined by soft agar [55], migration [55], telomere length [56], sequencing [57], aldefluor [58] and karyotyping assays [59].”
BackgroundIdentification and expansion of the tumorigenic lung cancer stem cell population
Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., Conticello, C., Ruco, L., Peschle, C., & De Maria, R. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402283 · Cited by 1,707
The Response of CD24 −/low /CD44 + Breast Cancer–Initiating Cells to Radiation
Phillips, T. M., McBride, W. H., & Pajonk, F. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj495 · Cited by 1,309
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Zhang, S., Balch, C., Chan, M. W., Lai, H.-C., Matei, D., Schilder, J. M., Yan, P. S., Huang, T. H.-M., & Nephew, K. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0364 · Cited by 1,293
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188 · cited 1×
“Different surface markers on different tissues provide a convenient platform of tumor initiating cells from tissues of liver [45, 46], breast [47], brain [48], lung [49], colon [50], pancreas [51] and intestine [52].”
BackgroundLineage Tracing Reveals Lgr5 + Stem Cell Activity in Mouse Intestinal Adenomas
Schepers, A. G., Snippert, H. J., Stange, D. E., van den Born, M., van Es, J. H., van de Wetering, M., & Clevers, H. (2012) · Science · doi:10.1126/science.1224676 · Cited by 1,072 · cited 1×
“Different surface markers on different tissues provide a convenient platform of tumor initiating cells from tissues of liver [45, 46], breast [47], brain [48], lung [49], colon [50], pancreas [51] and intestine [52].”
Kenny, P. A., Lee, G. Y., Myers, C. A., Neve, R. M., Semeiks, J. R., Spellman, P. T., Lorenz, K., Lee, E. H., Barcellos‐Hoff, M. H., PETERSEN, O. W., et al. (2008) · eScholarship (California Digital Library) · Cited by 1,039
Muraglia, A., Cancedda, R., & Quarto, R. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.7.1161 · Cited by 1,024
Cited by
From Donor to the Lab: A Fascinating Journey of Primary Cell Lines
Richter, M., Piwocka, O., Musielak, M., Piotrowski, I., Suchorska, W. M., & Trzeciak, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.711381 · Cited by 174
Jedrzejczak-Silicka, M. (2017) · New Insights into Cell Culture Technology · doi:10.5772/66905 · Cited by 87
Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems
Silva-Pedrosa, R., Salgado, A. J., & Ferreira, P. E. (2023) · Cells · doi:10.3390/cells12060930 · Cited by 84
Navigating challenges: optimising methods for primary cell culture isolation
Piwocka, O., Musielak, M., Ampuła, K., Piotrowski, I., Adamczyk, B., Fundowicz, M., Suchorska, W. M., & Malicki, J. (2024) · Cancer Cell International · doi:10.1186/s12935-023-03190-4 · Cited by 46
Pipiya, V. V., Gilazieva, Z. E., Issa, S. S., Rizvanov, A. A., & Solovyeva, V. V. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00237 · Cited by 23
Metadata
- Authors
- Mitra, A., Mishra, L., & Li, S.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 31
- Issue
- 6
- Pages
- 347-354
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W1972604432
- Cited by
- 193
- References
- 64
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.